Raw data of Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: randomized crossover clinical trial in healthy volunteers

Garrabou Tornos, GlòriaMartínez, Esteban2019-03-292019-03-292019-03https://hdl.handle.net/2445/131036Dades associades a l'article: Glòria Garrabou, Esteban Martínez. (2019): Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: randomized crossover clinical trial in healthy volunteers. Pendent de publicació a la revista PLOS ONE.application/vnd.ms-excelengcc-by (c) Garrabou Tornos, Glòria et al., 2019http://creativecommons.org/licenses/by/3.0/es/AntiretroviralsAssaigs clínics de medicamentsAntiretroviral agentsDrug testingRaw data of Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: randomized crossover clinical trial in healthy volunteersinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/openAccess